2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

5:18pm-5:30pm: Conversion from Tacrolimus to Belatacept in Pancreas Transplant Alone Recipients with Chronic Kidney Disease.

A. Sharfuddin, J. Chen, M. Yaqub, T. Taber, J. Powelson, D. Mishler, M. Goble, J. Fridell, O. Adebiyi, M. Mujtaba.

Concurrent Session: Clinical Pancreas Transplantation 2 • Room 210

5:18pm-5:30pm: Differential Regulation of the Microvascular Endothelial Cell Mediated Allogeneic CD4+ T Cell Response by Anti-HLA-DR and -DQ Alloantibodies in an Inflammatory Context.

N. Mooney,^1,2 A. Cross,^1,2 J. Lion,^1,2 A. Haziot,^1,2 D. Glotz.^1,2,3

Concurrent Session: B cells and Antibody-Mediated Rejection: Animal Models • Room 309

5:18pm-5:30pm: Glycine Is Graft Protective and Improves Kidney Function After Liver Transplantation: Data from HEGPOL-Trial.

A. Nickkholgh,¹ P. Schemmer,¹ G. Polychronidis,¹ S. Luntz,² E. Mayatepek,³ M. Büchler,¹ E. Klar.⁴

Concurrent Session: Ischemia Reperfusion Injury: Clinical Innovation • Room 311

5:18pm-5:30pm: Impact of Morbid Obesity on Breakthrough CMV Infection in Kidney Transplant Recipients.

S. Strout, N. Pilch, T. Veasey, R. Miller, J. Fleming, H. Meadows, C. Mardis, B. Mardis, P. Baliga, K. Chavin, D. Taber.

Concurrent Session: Diabetes and Obesity in Kidney Transplantation • Room 302

5:18pm-5:30pm: Induction Immunosuppression and Post-Transplant Outcomes in Kidney Recipients with Hepatitis C Virus.

S. Bae, C. Durand, L. Kucirka, A. Massie, D. Segev.

Concurrent Session: Kidney: Induction Therapy 2 • Room 312

5:18pm-5:30pm: Innate Lymphoid Cells Play a Key Role in Controlling Antimicrobial Defense in Intestinal Transplant Recipients.

J. Kaiser, C. Cosentino, A. Shukla, C. Desai, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.

Concurrent Session: Small Bowel Transplantation • Room 102

5:18pm-5:30pm: Lessons Learned Transplanting High KDPI Kidneys Over a Decade: Improvements in Graft Survival Stem from Lower Rates of Early Graft Loss.

S. Sanoff,¹ K. Ravindra, D. Vikraman, U. Patel, D. Sudan, W. Irish.²

Concurrent Session: The High KDPI Kidney: Outcomes and Optimal Utilization • Ballroom C

5:18pm-5:30pm: Lower Rates of Living Donor Kidney Transplantation(LD) Among African Americans: What Prevents Higher Rates of Donation?

A. Li, N. Foreman, M. Reissmann, C. Zuttermeister, A. Gilbert, M. Grafals, B. Javaid, S. Ghasemian, P. Abrams, M. Cooper, J. Verbesey.

Concurrent Session: Living Kidney Donor Evaluation • Ballroom B

5:18pm-5:30pm: Lower Renal Graft Function and Accelerated Fibrosis in HIV-Infected Transplant Recipients with Previous HIVAN Compared to Non HIVAN HIV-Positive Transplant Recipients.

M.-N. Peraldi,¹ H. Ayari,¹ M. Burbach,¹ C. Randoux,² E. Pillebout,¹ N. De Castro,³ J.-M. Molina,³ D. Glotz.¹

Concurrent Session: Kidney Transplant Recipient: Long Term Outcomes Session 2 • Ballroom A

5:18pm-5:30pm: Subtype-Compatible (A2/A2B–>B) Transplantation Under KAS Increases Access 3-Fold for Blood Type B Patients, yet Very Few Candidates Are Listed as Eligible.

D. Stewart,¹ W. Cherikh,¹ A. Kucheryavaya,¹ C. Bryan,² N. Turgeon,³ M. Aeder.⁴

Concurrent Session: Kidney Waitlist Management and KAS Initial Results • Veterans Auditorium